Form 4: ClearPoint Neuro CEO Joseph Burnett Reports Stock Transactions
SEC Form 4 Filing
ClearPoint Neuro's CEO, Joseph Burnett, reports the settlement of restricted stock units and shares withheld for tax obligations.
Summary
- On March 6, 2025, Joseph Michael Burnett, CEO and President of ClearPoint Neuro, Inc. [CLPT], engaged in transactions involving the company's common stock.
- Burnett settled 47,407 restricted stock units, receiving shares of common stock.
- Additionally, 26,160 shares were withheld to satisfy tax obligations at a price of $13.19 per share.
- Following these transactions, Burnett directly owns 271,123 shares of ClearPoint Neuro common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the CEO's stock ownership.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of stock transactions: settlement of restricted stock units and tax withholding. |
| 03/10/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.